These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies. Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627 [TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile: an update for the primary care clinician. Salkind AR South Med J; 2010 Sep; 103(9):896-902. PubMed ID: 20697321 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Rao K; Higgins PD Inflamm Bowel Dis; 2016 Jul; 22(7):1744-54. PubMed ID: 27120571 [TBL] [Abstract][Full Text] [Related]
11. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Kassam Z; Hundal R; Marshall JK; Lee CH Arch Intern Med; 2012 Jan; 172(2):191-3. PubMed ID: 22271132 [No Abstract] [Full Text] [Related]
12. Treatment of recurrent and severe Clostridium difficile infection. Keller JJ; Kuijper EJ Annu Rev Med; 2015; 66():373-86. PubMed ID: 25587656 [TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile Infection: An Orthopaedic Surgeon's Guide to Epidemiology, Management, and Prevention. Anderson PA; Bernatz J; Safdar N J Am Acad Orthop Surg; 2017 Mar; 25(3):214-223. PubMed ID: 28134674 [TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile in the long-term care setting. Makris AT; Gelone S J Am Med Dir Assoc; 2007 Jun; 8(5):290-9. PubMed ID: 17570307 [TBL] [Abstract][Full Text] [Related]
16. [Outcomes of Clostridium difficile enterocolitis after administration of antibiotics along with probiotic supplement]. Doder R; Kovacević N; Munćan D; Potkonjak A; Tomasev B; Ruzić M Med Pregl; 2013; 66(5-6):209-13. PubMed ID: 23888728 [TBL] [Abstract][Full Text] [Related]
17. Prevention of Clostridium difficile Infection With Probiotics. Evans CT; Johnson S Clin Infect Dis; 2015 May; 60 Suppl 2():S122-8. PubMed ID: 25922397 [TBL] [Abstract][Full Text] [Related]
18. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection. Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166 [TBL] [Abstract][Full Text] [Related]
19. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Surawicz CM; McFarland LV; Greenberg RN; Rubin M; Fekety R; Mulligan ME; Garcia RJ; Brandmarker S; Bowen K; Borjal D; Elmer GW Clin Infect Dis; 2000 Oct; 31(4):1012-7. PubMed ID: 11049785 [TBL] [Abstract][Full Text] [Related]
20. The changing face of Clostridium difficile: what treatment options remain? Shen EP; Surawicz CM Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]